Stay updated with breaking news from Sizhou guo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Search jobs HitGen and BioAge Announce Research Progress in DNA-Encoded Library Based Drug Discovery Research Collaboration CHENGDU, China (BUSINESS WIRE) Shanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a collaboration with BioAge Labs, Inc. (“BioAge”), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging. The companies have conducted collaborative research to identify and develop novel small-molecule compounds against a high-value and challenging biological target that is a critical component of the innate immune system. Dysregulation of this target is closely linked to the underlying cause of severe diseases in elderly humans, such as Alzheimer s and cardiovascular disease. ....
Posted on 259 Shanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a collaboration with BioAge Labs, Inc. (“BioAge”), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging. The companies have conducted collaborative research to identify and develop novel small-molecule compounds against a high-value and challenging biological target that is a critical component of the innate immune system. Dysregulation of this target is closely linked to the underlying cause of severe diseases in elderly humans, such as Alzheimer’s and cardiovascular disease. HitGen is a world leader in the development and applications of DNA encoded library (DEL) screening. The availability of over 1 trillion small molecules generated by DEL technology and the efficiency of the screening process have made it possible for ....